NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
Q4 2022 vs. Q3 2022
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 14 | +14 |
| Shares | 0 | 33.5M | +33.5M |
| Value | $0 | $362.2M | +$362.2M |
New holders (14)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,341,551 | $101.8M | 6.33% |
| Bain Capital Life Sciences Investors, LLC | 8,300,000 | $90.5M | 10.11% |
| Ra Capital Management, L.P. | 4,000,000 | $43.6M | 0.88% |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,753,828 | $39.5M | 0.20% |
| Deerfield Management Company, L.P. (Series C) | 2,480,199 | $27.0M | 0.56% |
| Medicxi Ventures Management (Jersey) Ltd | 2,000,000 | $21.8M | 9.16% |
| BVF Inc | 1,521,948 | $16.0M | 0.68% |
| GMT Capital Corp | 1,000,000 | $10.9M | 0.50% |
| Janus Henderson Group PLC | 563,119 | $5.33M | 0.00% |
| Ensign Peak Advisors, Inc | 355,000 | $3.87M | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $1.89M | 0.02% |
| JPMorgan Chase & Co | 1,102 | $12.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 88 | $1.00K | 0.00% |
| DuPont Capital Management Corp | 1 | $11 | 0.00% |
Sold out (0)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2022 and filed for Q4 2022 without it.
None.